AI

Alphabet Inc.

Momentum followerSector-focusedQuality / disciplined sizing

Total reported value

$4.0B

Reporting period: 2026-03-31 · Number of holdings: 27

Alphabet Inc. disclosed 27 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $4.0B and a quarterly turnover rate of 61.0%.

Browse other institutions with $1B to $10B AUMBrowse other institutions starting with "A"

Personality snowflake

Concentration
69.79
Portfolio Stability
60.98
Momentum/Contrarian
100
Sector conviction
83.25
Diversification
52
Sizing Uniformity
80.82

Recent moves

  • Trim ASTS

    0.0% $91.6M

  • Trim FRSH

    0.0% -$68.4M

  • Trim PATH

    0.0% -$37.2M

  • Trim GTLB

    0.0% -$43.3M

  • Trim RVMD

    -1.6% $53.8M

  • Trim TEM

    0.0% -$21.5M

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

Showing top 26 holdings (of 27 total)

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1CMECme Group INCStock-Financials25.63%+25.63%NEW
2PLPlanet Labs PbcStock-Industrials24.53%+0.11%+10.35%
3ASTSAst Spacemobile INCStock-Tech18.46%-6.72%
4RVMDRevolution Medicines INCStock-Healthcare7.97%-2.36%-1.57%
5ARMArm Holdings Plc-adrStock-Tech7.39%-0.92%
6FRSHFreshworks Inc-cl AStock-Other3.24%-4.46%
7PATHUipath INC - Class AStock-Tech1.94%-2.53%
8TEMTempus Ai Inc-cl AStock-Healthcare1.75%-1.80%
9PAYPPaypay CORPStock-Other1.66%+1.66%NEW
10GTLBGitlab Inc-cl AStock-Tech1.47%-2.49%
11PRMEPrime Medicine INCStock-Other1.44%-0.79%
12LIFEEthos Technologies INC Cl-aStock-Other1.05%+1.05%NEW
13MAZEMaze Therapeutics INCStock-Other1.03%-1.20%
14BBOTBridgebio Oncology TherapeutStock-Other0.63%-0.74%
15RLAYRelay Therapeutics INCStock-Other0.39%-0.12%-0.29%
16GLUEMonte Rosa Therapeutics INCStock-Other0.28%-0.17%-8.14%
17VERAVera Therapeutics INCStock-Other0.24%-0.23%
18SANASana Biotechnology INCStock-Other0.20%-0.24%
19BEAMBeam Therapeutics INCStock-Other0.19%-0.16%
20LYELLyell Immunopharma INCStock-Other0.15%-0.20%
21OSCROscar Health INC - Class AStock-Healthcare0.14%-0.13%
22FIGFigma Inc-cl AStock-Other0.11%-0.20%
23SPROSpero Therapeutics INCStock-Other0.05%-0.03%
24HYPRHyperfine INCStock-Other0.02%-0.01%
25AUTLAutolus Therapeutics PLCStock-Other0.02%-0.03%
26TNYATenaya Therapeutics INCStock-Other0.02%-0.01%

Holding changes this quarter

Alphabet Inc.'s most significant position changes for 2026-03-31: New buy: Cme Group INC (CME); Sold out: Dexcom INC (DXCM); New buy: Paypay CORP (PAYP); New buy: Ethos Technologies INC Cl-a (LIFE); Sold out: Genedx Holdings CORP (WGS).

Position changes disclosed by Alphabet Inc. for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1PLPlanet Labs Pbc+0.1%+10.35%Add
2HYPRHyperfine INC0%Unchanged
3TNYATenaya Therapeutics INC0%Unchanged
4AUTLAutolus Therapeutics PLC0%Unchanged
5SPROSpero Therapeutics INC0%Unchanged
6RLAYRelay Therapeutics INC-0.1%-0.29%Trim
7OSCROscar Health INC - Class A-0.1%Unchanged
8BEAMBeam Therapeutics INC-0.2%Unchanged
9GLUEMonte Rosa Therapeutics INC-0.2%-8.14%Trim
10FIGFigma Inc-cl A-0.2%Unchanged
11LYELLyell Immunopharma INC-0.2%Unchanged
12VERAVera Therapeutics INC-0.2%Unchanged
13SANASana Biotechnology INC-0.2%Unchanged
14BBOTBridgebio Oncology Therapeut-0.7%Unchanged
15PRMEPrime Medicine INC-0.8%Unchanged
16ARMArm Holdings Plc-adr-0.9%Unchanged
17MAZEMaze Therapeutics INC-1.2%Unchanged
18TEMTempus Ai Inc-cl A-1.8%Unchanged
19RVMDRevolution Medicines INC-2.4%-1.57%Trim
20GTLBGitlab Inc-cl A-2.5%Unchanged
21PATHUipath INC - Class A-2.5%Unchanged
22FRSHFreshworks Inc-cl A-4.5%Unchanged
23ASTSAst Spacemobile INC-6.7%Unchanged
24CMECme Group INCNEWNew buy
25DXCMDexcom INCEXITSold out
26PAYPPaypay CORPNEWNew buy
27LIFEEthos Technologies INC Cl-aNEWNew buy
28WGSGenedx Holdings CORPEXITSold out
29EXKExact Sciences CORPEXITSold out
30QNCXQuince Therapeutics, Inc.EXITSold out
31FULCFulcrum Therapeutics INCEXITSold out
32RGENRepligen CORPEXITSold out

FAQ

What is Alphabet Inc. and what type of investor is it?
Alphabet Inc. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $4.0B, spread across 27 disclosed positions.
What are Alphabet Inc.'s largest equity positions?
Based on the latest 13F filing, Alphabet Inc.'s top holdings by market value are: 1. Cme Group INC (CME) — $1.0B (25.6%) 2. Planet Labs Pbc (PL) — $985.2M (24.5%) 3. Ast Spacemobile INC (ASTS) — $741.1M (18.5%) 4. Revolution Medicines INC (RVMD) — $320.2M (8.0%) 5. Arm Holdings Plc-adr (ARM) — $296.6M (7.4%)
What changes did Alphabet Inc. make in its most recent portfolio filing?
In the latest reported quarter, Alphabet Inc. made 13 notable position adjustments: 3 new positions were initiated, 1 existing holdings were added to, 3 positions were partially reduced, and 6 were completely exited. The largest of these moves: New buy: Cme Group INC (CME); Sold out: Dexcom INC (DXCM); New buy: Paypay CORP (PAYP); New buy: Ethos Technologies INC Cl-a (LIFE); Sold out: Genedx Holdings CORP (WGS)
What sectors does Alphabet Inc. focus on?
Alphabet Inc. is concentrated in the following sectors based on its current disclosed equity portfolio: • Information Technology: 32.8% • Financials: 28.7% • Industrials: 27.5% • Health Care: 11.0%